Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
- 30 April 2003
- journal article
- Published by Elsevier BV in Urologic Oncology
- Vol. 21 (2), 123-127
- https://doi.org/10.1016/s1078-1439(02)00240-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Optimizing patient selection for prostate monotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2000
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJama-Journal Of The American Medical Association, 1998
- Microfocal prostate cancer: biopsy cancer volume does not predict actual tumour volumeBritish Journal of Urology, 1998
- Clinical significance of repeat sextant biopsies in prostate cancer patientsUrology, 1997
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerJAMA, 1994
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningJAMA, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958